Status:
UNKNOWN
Histology VABB-Histology Post Surgery Pilot Project (BETTY Trial)
Lead Sponsor:
European Institute of Oncology
Conditions:
Breast Cancer
Eligibility:
FEMALE
18-99 years
Brief Summary
Pilot study on patients with invasive ductal breast cancer triple negative or receptor tyrosine-protein kinase erbB-2 (HER2) overexpressed, any axillary lymphnodes status (any cN), candidates to neoad...
Detailed Description
The study articulates in five phases: Phase one: acquisition of the informed consent followed by positioning a clip into the cancer bed (by radiologist) if not already present; Phase two: after radio...
Eligibility Criteria
Inclusion
- age ≥ 18 aa;
- histological diagnosis done at European Institute of Oncology (if not, to does revision of pathological material);
- invasive ductal breast cancer triple negative or HER2 overexpressed, any cN;
- neoadjuvant standard systemic treatment after surgery +/- trastuzumab;
- propose of conservative or demolitive surgery;
- M0
- cancer bed identified pre neoadjuvant chemotherapy by clip
Exclusion
- multicentric or bilateral breast cancer
- mammography microcalcifications
- in situ breast carcinoma
- positive anamnesis for previous breast cancer
- positive anamnesis for medical or psychological conditions that prevent membership study
Key Trial Info
Start Date :
June 1 2018
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 31 2023
Estimated Enrollment :
22 Patients enrolled
Trial Details
Trial ID
NCT04365803
Start Date
June 1 2018
End Date
December 31 2023
Last Update
June 28 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
European Instituto of Oncology
Milan, Italy